U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma

MedGen UID:
1666301
•Concept ID:
C4727827
•
Neoplastic Process

Definition

A finding indicating the presence of a sarcoma arising from the soft tissue, other than rhabdomyosarcoma, that is resistant to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma

Recent clinical studies

Etiology

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
Gupta AA, Xue W, Harrison DJ, Hawkins DS, Dasgupta R, Wolden S, Shulkin B, Qumseya A, Routh JC, MacDonald T, Feinberg S, Crompton B, Rudzinski ER, Arnold M, Venkatramani R
Lancet Oncol 2024 Jul;25(7):912-921. doi: 10.1016/S1470-2045(24)00255-9. PMID: 38936378Free PMC Article

Therapy

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
Gupta AA, Xue W, Harrison DJ, Hawkins DS, Dasgupta R, Wolden S, Shulkin B, Qumseya A, Routh JC, MacDonald T, Feinberg S, Crompton B, Rudzinski ER, Arnold M, Venkatramani R
Lancet Oncol 2024 Jul;25(7):912-921. doi: 10.1016/S1470-2045(24)00255-9. PMID: 38936378Free PMC Article
High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours.
Aykan MB, Erturk I, Acar R, Yildiran GS, Yildiz B, Karadurmus N
J Coll Physicians Surg Pak 2022 Jan;32(1):51-56. doi: 10.29271/jcpsp.2022.01.51. PMID: 34983148

Clinical prediction guides

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
Gupta AA, Xue W, Harrison DJ, Hawkins DS, Dasgupta R, Wolden S, Shulkin B, Qumseya A, Routh JC, MacDonald T, Feinberg S, Crompton B, Rudzinski ER, Arnold M, Venkatramani R
Lancet Oncol 2024 Jul;25(7):912-921. doi: 10.1016/S1470-2045(24)00255-9. PMID: 38936378Free PMC Article
High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours.
Aykan MB, Erturk I, Acar R, Yildiran GS, Yildiz B, Karadurmus N
J Coll Physicians Surg Pak 2022 Jan;32(1):51-56. doi: 10.29271/jcpsp.2022.01.51. PMID: 34983148

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...